Opportunities and challenges for nutritional proteomics in cancer prevention

Journal of Nutrition

Volumn 142, Issue 7, 2012, Pages

  Romagnolo, Donato F ^a   Milner, John A ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLOPENTENONE; FATTY ACID; FLAVONOID; GARLIC EXTRACT; GREEN TEA EXTRACT; HISTONE; ISOFLAVONE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; MEMBRANE RECEPTOR; RESVERATROL; SELENIUM; THEOBROMA OIL; TRANSCRIPTION FACTOR; VITAMIN;

ARTICLE; BONE CANCER; BRASSICACEAE; BREAST CANCER; CANCER PREVENTION; COLON CANCER; DIET; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALIGNANT TRANSFORMATION; NEUROBLASTOMA; NONHUMAN; NUTRIENT SUPPLY; NUTRITIONAL PROTEOMICS; OVARY CANCER; PHENOTYPE; PROSTATE CANCER; PROTEOMICS; QUANTITATIVE ANALYSIS; STOMACH CANCER; VEGETABLE;

DIET; HUMANS; NEOPLASMS; NUTRITIONAL SCIENCES; PHENOTYPE; PROTEOME; PROTEOMICS;

EID: 84863551397     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.151803     Document Type: Article

References (110)

1. Milner JA. Nutrition in the 'omics' era. Forum Nutr. 2007;60:1-24.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequence analysis of the human genome. Nature. 2001;409:860-921.
3. Conney AH. Tailoring cancer chemoprevention regimens to the individual. J Cell Biochem. 2004;91:277-86.
4. Fortes C, Boffetta P. Nutritional epidemiological studies in cancer prevention: what went wrong, and how to move forwards. Eur J Cancer Prev. 2011;20:518-25.
5. Ghadirian P, Narod S, Fafard E, Costa M, Robidoux A, Nkondjock A. Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity. Breast Cancer Res Treat. 2009;117:417-22.
6. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann U. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat. 2007;104:299-308.
7. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004;16:166-77.
8. A gene-centric human proteome project: Hupo, The Human Proteome Organization. Mol Cell Proteomics. 2010;9:427-9.
9. Fuchs D, Winkelmann I, Johnson IT, Mariman E, Wenzel U, Daniel H. Proteomics in nutrition research: principles, technologies and applications. Br J Nutr. 2005;94:302-14.
10. Corthésy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Müller M, van Belzen N, van Ommen B. Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab. 2005;49:355-65.
11. Veenstra TD, Zhou M. Tissue proteomics and metabolomics: an excellent start and a promising future. J Proteome Res. 2009;8:1617.
12. Xiao Z, Mi L, Chung F-L, Veenstra TD. Proteomic analysis of covalent modifications of tubulins by isothiocyanates. J Nutr. 2012;142:1377S-81S.
13. de Roos B, Romagnolo DF. Proteomic approaches to predict bioavailability of fatty acids and their influence on cancer and chronic disease prevention. J Nutr. 2012;142:1370S-76S.
14. Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere C. Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol A and genistein. J Nutr. 2012;142:1382S-88S.
15. Ideker T, Sharan R. Protein networks in disease. Genome Res. 2008; 18:644-52.
16. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets. 2006;6:135-45.
17. Kemp MQ, Jeffy BD, Romagnolo DF. Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr. 2003;133:3670-7.
18. Rahal OM, Simmen RC. PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis. 2010;31:1491-500.
19. Afaq F, Khan N, Syed DN, Mukhtar H. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem Photobiol. 2010;86:1318-26.
20. Mousa AS, Mousa SA. Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr Cancer. 2005;53:104-10.
21. Kang SW, Choi JS, Choi YJ, Bae JY, Li J, Kim DS, Kim JL, Shin SY, Lee YJ, Kwun IS, et al. Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem. 2010;21: 55-65.
22. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000; 408:307-10.
23. Kastan MB, Bartek J. Cell-cycle checkpoints, cancer. Nature. 2004; 432:316-23.
24. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1997;1:3-11.
25. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 2001;20:1803-15.
26. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009;15: 1126-32.
27. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer. 2009;9:738-48.
28. Jensen ON. Interpreting the protein language using proteomics. Nat Rev Mol Cell Biol. 2006;7:391-403.
29. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9-18.
30. Garcia-Echeverria C, Sellers WR. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene. 2008;27:5511-26.
31. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635-48.
32. Sung MK, Yeon JY, Park SY, Park JH, Choi MS. Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci. 2011;1229:61-8.
33. Lahiry P, Torkamani A, Schork NJ, Hegele RA. Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat Rev Genet. 2010;11:60-74.
34. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J. 2005;392:249-61.
35. Leroy C, Fialin C, Sirvent A, Simon V, Urbach S, Poncet J, Robert B, Jouin P, Roche S. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res. 2009;69:2279-86.
36. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003;22:337-58.
37. Yan GR, Xiao CL, He GW, Yin XF, Chen NP, Cao Y, He QY. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics. 2010;10:976-86.
38. Fuchs D, Vafeiadou K, Hall WL, Daniel H, Williams CM, Schroot JH, Wenzel U. Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am J Clin Nutr. 2007;86:1369-75.
39. Resh MD. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE. 2006;2006:re14.
40. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell. 2005;16:231-7.
41. Seo J, Barhoumi R, Johnson AE, Lupton JR, Chapkin RS. Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J. 2006;20:770-2.
42. Mallick P, Kuster B. Proteomics: a pragmatic perspective. Nat Biotechnol. 2010;28:695-709.
43. Domon B, Aebersold R. Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol. 2010;28:710-21.
44. Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat RevMol Cell Biol. 2010;11:427-39.
45. Cecconi D, Zamò A, Parisi A, Bianchi E, Parolini C, Timperio AM, Zolla L, Chilosi M. Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. J Proteome Res. 2008;7:2670-80.
46. Mastrangelo L, Cassidy A, Mulholland F, Wang W, Bao Y. Serotonin receptors, novel targets of sulforaphane identified by proteomic analysis in Caco-2 cells. Cancer Res. 2008;68:5487-91.
47. Lee CH, Jeong SJ, Yun SM, Kim JH, Lee HJ, Ahn KS, Won SH, Kim HS, Lee HJ, Ahn KS, et al. Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells. Proteome Sci. 2010;8:67.
48. Mi L, Xiao Z, Hood BL, Dakshanamurthy S, Wang X, Govind S, Conrads TP, Veenstra TD, Chung FL. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem. 2008;283:22136-46.
49. Wang J, Betancourt AM, Mobley JA, Lamartiniere CA. Proteomic discovery of genistein action in the rat mammary gland. J Proteome Res. 2011;10:1621-31.
50. Mi L, Xiao Z, Veenstra TD, Chung FL. Proteomic identification of binding targets of isothiocyanates: a perspective on techniques. J Proteomics. 2011;74:1036-44.
51. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1:845-67.
52. Brauer HA, Libby TE, Mitchell BL, Li L, Chen C, Randolph TW, Yasui YY, Lampe JW, Lampe PD. Cruciferous vegetable supplementation in a controlled diet study alters the serum peptidome in a GSTM1-genotype dependent manner. Nutr J. 2011;10:11.
53. Yan GR, Yin XF, Xiao CL, Tan ZL, Xu SH, He QY. Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics. J Proteomics. 2011;75:695-707.
54. Macek B, Mann M, Olsen JV. Global and site-specific quantitative phosphoproteomics: principles and applications. Annu Rev Pharmacol Toxicol. 2009;49:199-221.
55. Albrethsen J. The first decade of MALDI protein profiling: a lesson in translational biomarker research. J Proteomics. 2011;74:765-73.
56. Liuni P, Wilson DJ. Understanding and optimizing electrospray ionization techniques for proteomic analysis. Expert Rev Proteomics. 2011;8:197-209.
57. Elschenbroich S, Kislinger T. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol Biosyst. 2011;7:292-303.
58. The Human Protein Atlas [cited April 15, 2012]. Available from: www. proteinatlas.org.
59. Agyeman AS, Chaerkady R, Shaw PG, Davidson NE, Visvanathan K, Pandey A, Kensler TW. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res Treat. 2012;132:175-87.
60. Kassie F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, Hecht SS. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res. 2007;67:6502-11.
61. Wabnitz GH, Goursot C, Jahraus B, Kirchgessner H, Hellwig A, Klemke M, Konstandin MH, Samstag Y. Mitochondrial translocation of oxidized cofilin induces caspase-independent necrotic-like programmed cell death of T cells. Cell Death Dis. 2010;1:e58.
62. Sabidó E, Selevsek N, Aebersold R. Mass spectrometry-based proteomics for systems biology. Curr Opin Biotechnol. 2011;23:1-7.
63. Sardiu ME, WashburnMP. Building protein-protein interaction networks with proteomics and informatics tools. J Biol Chem. 2011;286: 23645-51.
64. Zhang GL, DeLuca DS, Brusic V. Database resources for proteomicsbased analysis of cancer. Methods Mol Biol. 2011;723:349-64.
65. Pontén F, Jirström K, Uhlen M. The human protein atlas: a tool for pathology. J Pathol. 2008;216:387-93.
66. Boja E, Hiltke T, Rivers R, Kinsinger C, Rahbar A, Mesri M, Rodriguez H. Evolution of clinical proteomics and its role in medicine. J Proteome Res. 2011;10:66-84.
67. Pontén F, Gry M, Fagerberg L, Lundberg E, Asplund A, Berglund L, Oksvold P, Björling E, Hober S, Kampf C, et al. A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol. 2009;5:337.
68. Britton LM, Gonzales-Cope M, Zee BM, Garcia BA. Breaking the histone code with quantitative mass spectrometry. Expert Rev Proteomics. 2011;8:631-43.
69. Lin RK, Zhou N, Lyu YL, Tsai YC, Lu CH, Kerrigan J, Chen YT, Guan Z, Hsieh TS, Liu LF. Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIa. J Biol Chem. 2011; 286:33591-600.
70. Jeon YK, Yoo DR, Jang YH, Jang SY, Nam MJ. Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochim Biophys Act. 2011;1814:1340-8.
71. Neo JC, Rose P, Ong CN, Chung MC. b-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics. 2005;5:1075-82.
72. Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, Singh SV. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst. 2011;103:571-84.
73. Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, Templeton DJ. Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem J. 2009;423:315-21.
74. Hoelzl C, Lorenz O, Haudek V, Gundacker N, Knasmüller S, Gerner C. Proteome alterations induced in human white blood cells by consumption of Brussels sprouts: results of a pilot intervention study. Proteomics Clin Appl. 2008;2:108-17.
75. Mitchell BL, Yasui Y, Lampe JW, Gafken PR, Lampe PD. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet. Proteomics. 2005;5:2238-46.
76. Breikers G, van Breda SG, Bouwman FG, van Herwijnen MH, Renes J, Mariman EC, Kleinjans JC, van Delft JH. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis. Proteomics. 2006;6:2844-52.
77. Opii WO, Joshi G, Head E, Milgram NW, Muggenburg BA, Klein JB, Pierce WM, Cotman CW, Butterfield DA. Proteomic identification of brain proteins in the canine model of human aging following a longterm treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging. 2008; 29:51-70.
78. Rowell C, Carpenter DM, Lamartiniere CA. Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J Nutr. 2005;135:S2953-9.
79. Zhang D, Tai YC, Wong CH, Tai LK, Koay ES, Chen CS. Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study. Leuk Res. 2007;31:75-82.
80. Fuchs D, Erhard P, Rimbach G, Daniel H, Wenzel U. Genistein blocks homocysteine-induced alterations in the proteome of human endothelial cells. Proteomics. 2005;5:2808-18.
81. Pakalapati G, Li L, Gretz N, Koch E, Wink M. Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats. Phytomedicine. 2009;16:845-55.
82. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004;4:2160-74.
83. Dihal AA, van der Woude H, Hendriksen PJ, Charif H, Dekker LJ, Ijsselstijn L, de Boer VC, Alink GM, Burgers PC, Rietjens IM, et al. Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics. 2008;8:45-61.
84. Mouat MF, Kolli K, Orlando R, Hargrove JL, Grider A. The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J. 2005;4:11.
85. Zhou J, Liang S, Fang L, Chen L, Tang M, Xu Y, Fu A, Yang J, Wei Y. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009;13:93-103.
86. Zanini C, Giribaldi G, Mandili G, Carta F, Crescenzio N, Bisaro B, Doria A, Foglia L, di Montezemolo LC, Timeus F, et al. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. J Neurochem. 2007;103:1344-54.
87. Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics. 2003;3:1904-11.
88. Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate. 2008;68:1773-89.
89. Herzog A, Kindermann B, Döring F, Daniel H, Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics. 2004;4:2455-64.
90. de Roos B, Geelen A, Ross K, Rucklidge G, Reid M, Duncan G, Caslake M, Horgan G, Brouwer IA. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics. 2008;8: 1965-74.
91. de Roos B, Duivenvoorden I, Rucklidge G, Reid M, Ross K, Lamers RJ, Voshol PJ, Havekes LM, Teusink B. Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data. FASEB J. 2005;19:813-5.
92. de Roos B, Rucklidge G, Reid M, Ross K, Duncan G, Navarro MA, Arbones-Mainar JM, Guzman-Garcia MA, Osada J, Browne J, et al. Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. FASEB J. 2005; 19:1746-8.
93. Tan HT, Tan S, Lin Q, Lim TK, Hew CL, Chung MC. Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells. Mol Cell Proteomics. 2008;7:1174-85.
94. Tan S, Seow TK, Liang RC, Koh S, Lee CP, Chung MC, Hooi SC. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer. 2002;98:523-31.
95. Fung KY, Lewanowitsch T, Henderson ST, Priebe I, Hoffmann P, McColl SR, Lockett T, Head R, Cosgrove LJ. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells. J Proteome Res. 2009;8:1220-7.
96. Gharbi S, Garzón B, Gayarre J, Timms J, Pérez-Sala D. Study of protein targets for covalent modification by the antitumoral and antiinflammatory prostaglandin PGA1: focus on vimentin. J Mass Spectrom. 2007;42:1474-84.
97. Deshane J, Chaves L, Sarikonda KV, Isbell S, Wilson L, Kirk M, Grubbs C, Barnes S, Meleth S, Kim H. Proteomics analysis of rat brain protein modulations by grape seed extract. J Agric Food Chem. 2004; 52:7872-83.
98. Lee SC, Chan J, Clement MV, Pervaiz S. Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics. 2006;6: 2386-94.
99. Narayanan NK, Narayanan BA, Nixon DW. Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: twodimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation. Cancer Detect Prev. 2004; 28:443-52.
100. Li N, Guo R, LiW, Shao J, Li S, Zhao K, Chen X, Xu N, Liu S, Lu Y. A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide. Carcinogenesis. 2006;27:1222-31.
101. Zhang YK, Zhang XH, Li JM, Sun de S, Yang Q, Diao DM. A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide. Anticancer Drugs. 2009;20:702-12.
102. Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP, Dubinett SM, Sondej MA, Loo JA, Rao JY. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics. 2009;9:757-67.
103. Weinreb O, Amit T, Youdim MB. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidantiron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic Biol Med. 2007;43:546-56.
104. Ramljak D, Romanczyk LJ, Metheny-Barlow LJ, Thompson N, Knezevic V, Galperin M, Ramesh A, Dickson RB. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther. 2005;4:537-46.
105. Mahn AV, Toledo HM, Ruz M. Dietary supplementation with selenomethylselenocysteine produces a differential proteomic response. J Nutr Biochem. 2009;20:791-9.
106. Wang Y, He QY, Chen H, Chiu JF. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization. Exp Cell Res. 2007;313:357-68.
107. Laserna EJ, Valero ML, Sanz L, del Pino MM, Calvete JJ, Barettino D. Proteomic analysis of phosphorylated nuclear proteins underscores novel roles for rapid actions of retinoic acid in the regulation of mRNA splicing and translation. Mol Endocrinol. 2009;23:1799-814.
108. Park S, Lee J, Yeom CH. A proteomic approach to the identification of early molecular targets changed by L-ascorbic acid in NB4 human leukemia cells. J Cell Biochem. 2006;99:1628-41.
109. Duthie SJ, Horgan G, de Roos B, Rucklidge G, Reid M, Duncan G, Pirie L, Basten GP, Powers HJ. Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J Proteome Res. 2010;9:1941-50.
110. Duthie SJ, Mavrommatis Y, Rucklidge G, Reid M, Duncan G, Moyer MP, Pirie LP, Bestwick CS. The response of human colonocytes to folate deficiency invitro: functional andproteomic analyses. J ProteomeRes.2008;7:3254-66.